Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 111

1.

Comment on: Wiser et al. Ovarian cancer in Switzerland: incidence and treatment according to hospital registry data. Swiss Med Wkly.2018;148:w14647.

Feller A, Bopp M, Lorez M, Zellweger U, Adam M, Curjuric I, Staehelin K, Perren A, Bergeron Y, Rapiti E, Mousavi M, Diebold J, Dyntar D, Bulliard JL, Maspoli Conconi M, Bordoni A, Konzelmann I, Wagner U, Rohrmann S.

Swiss Med Wkly. 2020 Feb 7;150:w20179. doi: 10.4414/smw.2020.20179. eCollection 2020 Jan 27. No abstract available.

2.

A population-based cohort of young women diagnosed with breast cancer in Geneva, Switzerland.

Schaffar R, Bouchardy C, Chappuis PO, Bodmer A, Benhamou S, Rapiti E.

PLoS One. 2019 Sep 6;14(9):e0222136. doi: 10.1371/journal.pone.0222136. eCollection 2019.

3.

Testicular cancer in Geneva, Switzerland, 1970-2012: incidence trends, survival and risk of second cancer.

Schaffar R, Pant S, Bouchardy C, Schubert H, Rapiti E.

BMC Urol. 2019 Jul 10;19(1):64. doi: 10.1186/s12894-019-0494-0.

4.

Impact of experience in breast cancer surgery on survival: the role of quality of care in a registry-based cohort.

Taban F, Elia N, Rapiti E, Rageth C, Fioretta G, Benhamou S, Than Lam G, David-Montefiore E, Bouchardy C.

Swiss Med Wkly. 2019 Jan 27;149:w14704. doi: 10.4414/smw.2019.14704. eCollection 2019 Jan 14.

5.

Comorbidities, age and period of diagnosis influence treatment and outcomes in early breast cancer.

Minicozzi P, Van Eycken L, Molinie F, Innos K, Guevara M, Marcos-Gragera R, Castro C, Rapiti E, Katalinic A, Torrella A, Žagar T, Bielska-Lasota M, Giorgi Rossi P, Larrañaga N, Bastos J, Sánchez MJ, Sant M; European HR Working Group on breast cancer.

Int J Cancer. 2019 May 1;144(9):2118-2127. doi: 10.1002/ijc.31974. Epub 2018 Dec 27.

PMID:
30411340
6.

Impact of subtypes and comorbidities on breast cancer relapse and survival in population-based studies.

Ess SM, Herrmann C, Bouchardy C, Neyroud I, Rapiti E, Konzelmann I, Bordoni A, Ortelli L, Rohrmann S, Frick H, Mousavi M, Thürlimann B.

Breast. 2018 Oct;41:151-158. doi: 10.1016/j.breast.2018.07.011. Epub 2018 Jul 30.

PMID:
30099326
7.

Breast cancer family history leads to early breast cancer detection and optimal management.

Jannot AS, Usel M, Bouchardy C, Schubert H, Rapiti E.

Cancer Causes Control. 2017 Sep;28(9):921-928. doi: 10.1007/s10552-017-0928-5. Epub 2017 Jul 27.

PMID:
28752191
8.

Opportunities for improving triple-negative breast cancer outcomes: results of a population-based study.

Rapiti E, Pinaud K, Chappuis PO, Viassolo V, Ayme A, Neyroud-Caspar I, Usel M, Bouchardy C.

Cancer Med. 2017 Mar;6(3):526-536. doi: 10.1002/cam4.998. Epub 2017 Feb 17.

9.

Right colon cancer: Left behind.

Gervaz P, Usel M, Rapiti E, Chappuis P, Neyroud-Kaspar I, Bouchardy C.

Eur J Surg Oncol. 2016 Sep;42(9):1343-9. doi: 10.1016/j.ejso.2016.04.002. Epub 2016 Apr 23.

PMID:
27178778
10.

Stage IVB endometrial cancer: clinical course and survival of patients with single and multiple metastases.

Kraemer O, Rapiti E, Huber D, Lopes-Raimundo E, Usel M, Bouchardy C, Petignat P.

Eur J Gynaecol Oncol. 2015;36(5):529-32.

PMID:
26513877
11.

Breast cancer in younger women in Switzerland 1996-2009: a longitudinal population-based study.

Bodmer A, Feller A, Bordoni A, Bouchardy C, Dehler S, Ess S, Levi F, Konzelmann I, Rapiti E, Steiner A, Clough-Gorr KM; NICER Working Group.

Breast. 2015 Apr;24(2):112-7. doi: 10.1016/j.breast.2014.11.004. Epub 2014 Dec 15.

PMID:
25522906
12.

Determinants and effects of positive surgical margins after prostatectomy on prostate cancer mortality: a population-based study.

Retèl VP, Bouchardy C, Usel M, Neyroud-Caspar I, Schmidlin F, Wirth G, Iselin C, Miralbell R, Rapiti E.

BMC Urol. 2014 Nov 5;14:86. doi: 10.1186/1471-2490-14-86.

13.

Aggressiveness of cancer treatment in patients hospitalized in a supportive care unit.

Luthy C, Pugliesi A, Rapiti E, Kossovsky M, Dietrich PY, Cedraschi C, Allaz AF.

Support Care Cancer. 2015 Feb;23(2):325-31. doi: 10.1007/s00520-014-2341-x. Epub 2014 Jul 31.

PMID:
25077805
14.

Cancer registries can provide evidence-based data to improve quality of care and prevent cancer deaths.

Bouchardy C, Rapiti E, Benhamou S.

Ecancermedicalscience. 2014 Mar 28;8:413. doi: 10.3332/ecancer.2014.413. eCollection 2014.

15.

Determinants of genetic counseling uptake and its impact on breast cancer outcome: a population-based study.

Ayme A, Viassolo V, Rapiti E, Fioretta G, Schubert H, Bouchardy C, Chappuis PO, Benhamou S.

Breast Cancer Res Treat. 2014 Apr;144(2):379-89. doi: 10.1007/s10549-014-2864-3. Epub 2014 Feb 12.

PMID:
24519389
16.

Planning for the future: cancer incidence projections in Switzerland up to 2019.

Rapiti E, Guarnori S, Pastoors B, Miralbell R, Usel M.

BMC Public Health. 2014 Feb 1;14:102. doi: 10.1186/1471-2458-14-102.

17.
18.

Central pain sensitization, COMT Val158Met polymorphism, and emotional factors in fibromyalgia.

Desmeules J, Chabert J, Rebsamen M, Rapiti E, Piguet V, Besson M, Dayer P, Cedraschi C.

J Pain. 2014 Feb;15(2):129-35. doi: 10.1016/j.jpain.2013.10.004. Epub 2013 Oct 20.

PMID:
24342707
19.

Impact of family history of breast cancer on tumour characteristics, treatment, risk of second cancer and survival among men with breast cancer.

Bouchardy C, Rapiti E, Fioretta G, Schubert H, Chappuis P, Vlastos G, Benhamou S.

Swiss Med Wkly. 2013 Nov 12;143:w13879. doi: 10.4414/smw.2013.13879. eCollection 2013.

20.

How many ovarian cancer patients are eligible for fertility-sparing surgery?

Huber D, Cimorelli V, Usel M, Bouchardy C, Rapiti E, Petignat P.

Eur J Obstet Gynecol Reprod Biol. 2013 Sep;170(1):270-4. doi: 10.1016/j.ejogrb.2013.06.039. Epub 2013 Jul 22.

PMID:
23886771
21.

Importance and determinants of Gleason score undergrading on biopsy sample of prostate cancer in a population-based study.

Rapiti E, Schaffar R, Iselin C, Miralbell R, Pelte MF, Weber D, Zanetti R, Neyroud-Caspar I, Bouchardy C.

BMC Urol. 2013 Apr 11;13:19. doi: 10.1186/1471-2490-13-19.

22.

Assessment of fluorescent particles for surface flow analysis.

Tauro F, Mocio G, Rapiti E, Grimaldi S, Porfiri M.

Sensors (Basel). 2012 Nov 14;12(11):15827-40. doi: 10.3390/s121115827.

23.

Breast cancer management and outcome according to surgeon's affiliation: a population-based comparison adjusted for patient's selection bias.

Taban F, Rapiti E, Fioretta G, Wespi Y, Weintraub D, Hugli A, Schubert H, Vlastos G, Castiglione M, Bouchardy C.

Ann Oncol. 2013 Jan;24(1):116-25. doi: 10.1093/annonc/mds285. Epub 2012 Sep 3.

24.

Risk, characteristics, and prognosis of breast cancer after Hodgkin's lymphoma.

Veit-Rubin N, Rapiti E, Usel M, Benhamou S, Vinh-Hung V, Vlastos G, Bouchardy C.

Oncologist. 2012;17(6):783-91. doi: 10.1634/theoncologist.2011-0451. Epub 2012 May 15.

25.

Changes in incidence, survival and mortality of prostate cancer in Europe and the United States in the PSA era: additional diagnoses and avoided deaths.

Neppl-Huber C, Zappa M, Coebergh JW, Rapiti E, Rachtan J, Holleczek B, Rosso S, Aareleid T, Brenner H, Gondos A; EUNICE Survival Working Group.

Ann Oncol. 2012 May;23(5):1325-1334. doi: 10.1093/annonc/mdr414. Epub 2019 Dec 4.

PMID:
32018596
26.

Changes in incidence, survival and mortality of prostate cancer in Europe and the United States in the PSA era: additional diagnoses and avoided deaths.

Neppl-Huber C, Zappa M, Coebergh JW, Rapiti E, Rachtan J, Holleczek B, Rosso S, Aareleid T, Brenner H, Gondos A; EUNICE Survival Working Group.

Ann Oncol. 2012 May;23(5):1325-34. doi: 10.1093/annonc/mdr414. Epub 2011 Sep 28.

27.

Antiestrogen therapy for breast cancer modifies the risk of subsequent cutaneous melanoma.

Huber C, Bouchardy C, Schaffar R, Neyroud-Caspar I, Vlastos G, Le Gal FA, Rapiti E, Benhamou S.

Cancer Prev Res (Phila). 2012 Jan;5(1):82-8. doi: 10.1158/1940-6207.CAPR-11-0332. Epub 2011 Sep 20.

28.

Psychological distress in fibromyalgia patients: a role for catechol-O-methyl-transferase Val158met polymorphism.

Desmeules J, Piguet V, Besson M, Chabert J, Rapiti E, Rebsamen M, Rossier MF, Curtin F, Dayer P, Cedraschi C.

Health Psychol. 2012 Mar;31(2):242-249. doi: 10.1037/a0025223. Epub 2011 Sep 5.

PMID:
21895373
29.

Omission of excisional therapy is associated with an increased risk of invasive cervical cancer after cervical intraepithelial neoplasia III.

Rapiti E, Usel M, Neyroud-Caspar I, Merglen A, Verkooijen HM, Vlastos AT, Pache JC, Kumar N, Bouchardy C.

Eur J Cancer. 2012 Apr;48(6):845-52. doi: 10.1016/j.ejca.2011.05.002.

PMID:
21658934
30.

Breast cancer prognosis is inherited independently of patient, tumor and treatment characteristics.

Verkooijen HM, Hartman M, Usel M, Benhamou S, Neyroud-Caspar I, Czene K, Vlastos G, Chappuis PO, Bouchardy C, Rapiti E.

Int J Cancer. 2012 May 1;130(9):2103-10. doi: 10.1002/ijc.26206. Epub 2011 Nov 17.

31.

Local-regional radiotherapy and surgery is associated with a significant survival advantage in metastatic breast cancer patients.

Ly BH, Vlastos G, Rapiti E, Vinh-Hung V, Nguyen NP.

Tumori. 2010 Nov-Dec;96(6):947-54.

PMID:
21388057
32.

Lung cancer mortality risk among breast cancer patients treated with anti-estrogens.

Bouchardy C, Benhamou S, Schaffar R, Verkooijen HM, Fioretta G, Schubert H, Vinh-Hung V, Soria JC, Vlastos G, Rapiti E.

Cancer. 2011 Mar 15;117(6):1288-95. doi: 10.1002/cncr.25638. Epub 2011 Jan 24.

33.

Prognostic value of axillary lymph node status after neoadjuvant chemotherapy. Results from a multicentre study.

Saxena N, Hartman M, Aziz R, Rapiti E, Bhoo Pathy N, Lim SE, Iau P, Taib NA, Schaffar R, Neyroud-Caspar I, Yip CH, Lee SC, Verkooijen HM.

Eur J Cancer. 2011 May;47(8):1186-92. doi: 10.1016/j.ejca.2010.12.009. Epub 2011 Jan 14.

PMID:
21239165
34.

Re: Fruit and vegetable intake and overall cancer risk in the European Prospective Investigation into Cancer and Nutrition.

Bouchardy C, Benhamou S, Rapiti E.

J Natl Cancer Inst. 2011 Feb 2;103(3):279; author reply 280-1. doi: 10.1093/jnci/djq501. Epub 2010 Dec 16. No abstract available.

PMID:
21163905
35.

Risk of second breast cancer according to estrogen receptor status and family history.

Bouchardy C, Benhamou S, Fioretta G, Verkooijen HM, Chappuis PO, Neyroud-Caspar I, Castiglione M, Vinh-Hung V, Vlastos G, Rapiti E.

Breast Cancer Res Treat. 2011 May;127(1):233-41. doi: 10.1007/s10549-010-1137-z. Epub 2010 Sep 29.

PMID:
20878464
36.

Incidence rates of thyroid cancer and myeloid leukaemia in French Polynesia.

Bouchardy C, Benhamou S, de Vathaire F, Schaffar R, Rapiti E.

Int J Cancer. 2011 May 1;128(9):2241-3. doi: 10.1002/ijc.25545. No abstract available.

37.

Patients' views about causes and preferences for the management of cancer-related fatigue-a case for non-congruence with the physicians?

Luthy C, Cedraschi C, Pugliesi A, Di Silvestro K, Mugnier-Konrad B, Rapiti E, Allaz AF.

Support Care Cancer. 2011 Mar;19(3):363-70. doi: 10.1007/s00520-010-0826-9. Epub 2010 Feb 19.

PMID:
20169368
38.

Loco-regional treatment in metastatic breast cancer patients: is there a survival benefit?

Ly BH, Nguyen NP, Vinh-Hung V, Rapiti E, Vlastos G.

Breast Cancer Res Treat. 2010 Feb;119(3):537-45. doi: 10.1007/s10549-009-0610-z. Review.

PMID:
19876731
39.

Impact of socioeconomic status on prostate cancer diagnosis, treatment, and prognosis.

Rapiti E, Fioretta G, Schaffar R, Neyroud-Caspar I, Verkooijen HM, Schmidlin F, Miralbell R, Zanetti R, Bouchardy C.

Cancer. 2009 Dec 1;115(23):5556-65. doi: 10.1002/cncr.24607.

40.

The incidence of breast cancer and changes in the use of hormone replacement therapy: a review of the evidence.

Verkooijen HM, Bouchardy C, Vinh-Hung V, Rapiti E, Hartman M.

Maturitas. 2009 Oct 20;64(2):80-5. doi: 10.1016/j.maturitas.2009.07.015. Epub 2009 Aug 25. Review.

PMID:
19709827
41.

Excess of cardiovascular mortality among node-negative breast cancer patients irradiated for inner-quadrant tumors.

Bouchardy C, Rapiti E, Usel M, Majno SB, Vlastos G, Benhamou S, Miralbell R, Neyroud-Caspar I, Verkooijen HM, Vinh-Hung V.

Ann Oncol. 2010 Mar;21(3):459-65. doi: 10.1093/annonc/mdp341. Epub 2009 Aug 24.

42.

Impact of a positive family history on diagnosis, management, and survival of breast cancer: different effects across socio-economic groups.

Verkooijen HM, Rapiti E, Fioretta G, Vinh-Hung V, Keller J, Benhamou S, Vlastos G, Chappuis PO, Bouchardy C.

Cancer Causes Control. 2009 Nov;20(9):1689-96. doi: 10.1007/s10552-009-9420-1. Epub 2009 Aug 22.

PMID:
19701688
43.

Changing pattern of age-specific breast cancer incidence in the Swiss canton of Geneva.

Bouchardy C, Usel M, Verkooijen HM, Fioretta G, Benhamou S, Neyroud-Caspar I, Schaffar R, Vlastos G, Wespi Y, Schäfer P, Rapiti E.

Breast Cancer Res Treat. 2010 Apr;120(2):519-23. doi: 10.1007/s10549-009-0478-y. Epub 2009 Jul 25.

PMID:
19633953
44.

Impact of obesity on diagnosis and treatment of breast cancer.

Deglise C, Bouchardy C, Burri M, Usel M, Neyroud-Caspar I, Vlastos G, Chappuis PO, Ceschi M, Ess S, Castiglione M, Rapiti E, Verkooijen HM.

Breast Cancer Res Treat. 2010 Feb;120(1):185-93. doi: 10.1007/s10549-009-0459-1. Epub 2009 Jul 14.

PMID:
19597985
45.

Young patients with endometrial cancer: how many could be eligible for fertility-sparing treatment?

Navarria I, Usel M, Rapiti E, Neyroud-Caspar I, Pelte MF, Bouchardy C, Petignat P.

Gynecol Oncol. 2009 Sep;114(3):448-51. doi: 10.1016/j.ygyno.2009.05.038. Epub 2009 Jun 27.

PMID:
19560801
46.

Estimated dose to the rectum and colon in prostate cancer patients treated with exclusive radiation therapy presenting a secondary colorectal malignancy.

Weber DC, Wang H, Bouchardy C, Rosset A, Rapiti E, Schmidlin F, Rouzaud M, Miralbell R.

Clin Oncol (R Coll Radiol). 2009 Nov;21(9):687-94. doi: 10.1016/j.clon.2009.05.008. Epub 2009 Jun 21.

PMID:
19541463
47.

Characteristics and outcome of prostate cancer with PSA <4 ng/ml at diagnosis: a population-based study.

Bonet M, Merglen A, Fioretta G, Rapiti E, Neyroud-Caspar I, Zanetti R, Miralbell R, Bouchardy C.

Clin Transl Oncol. 2009 May;11(5):312-7.

PMID:
19451064
48.

Lymph node ratio as an alternative to pN staging in node-positive breast cancer.

Vinh-Hung V, Verkooijen HM, Fioretta G, Neyroud-Caspar I, Rapiti E, Vlastos G, Deglise C, Usel M, Lutz JM, Bouchardy C.

J Clin Oncol. 2009 Mar 1;27(7):1062-8. doi: 10.1200/JCO.2008.18.6965. Epub 2009 Jan 21.

PMID:
19164210
49.

Hormonal therapy for oestrogen receptor-negative breast cancer is associated with higher disease-specific mortality.

Merglen A, Verkooijen HM, Fioretta G, Neyroud-Caspar I, Vinh-Hung V, Vlastos G, Chappuis PO, Castiglione M, Rapiti E, Bouchardy C.

Ann Oncol. 2009 May;20(5):857-61. doi: 10.1093/annonc/mdn688. Epub 2009 Jan 15.

50.

Increased risk of colon cancer after external radiation therapy for prostate cancer.

Rapiti E, Fioretta G, Verkooijen HM, Zanetti R, Schmidlin F, Shubert H, Merglen A, Miralbell R, Bouchardy C.

Int J Cancer. 2008 Sep 1;123(5):1141-5. doi: 10.1002/ijc.23601.

Supplemental Content

Loading ...
Support Center